Sokołowska-Wojdyło M, Olek-Hrab K, Ruckemann-Dziurdzińska K. Primary cutaneous lymphomas: diagnosis and treatment. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2015;32(5):368-383. doi:10.5114/pdia.2015.54749.
APA
Sokołowska-Wojdyło, M., Olek-Hrab, K., & Ruckemann-Dziurdzińska, K. (2015). Primary cutaneous lymphomas: diagnosis and treatment. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 32(5), 368-383. https://doi.org/10.5114/pdia.2015.54749
Chicago
Sokołowska-Wojdyło, Małgorzata, Karolina Olek-Hrab, and Katarzyna Ruckemann-Dziurdzińska. 2015. "Primary cutaneous lymphomas: diagnosis and treatment". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 32 (5): 368-383. doi:10.5114/pdia.2015.54749.
Harvard
Sokołowska-Wojdyło, M., Olek-Hrab, K., and Ruckemann-Dziurdzińska, K. (2015). Primary cutaneous lymphomas: diagnosis and treatment. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 32(5), pp.368-383. https://doi.org/10.5114/pdia.2015.54749
MLA
Sokołowska-Wojdyło, Małgorzata et al. "Primary cutaneous lymphomas: diagnosis and treatment." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 32, no. 5, 2015, pp. 368-383. doi:10.5114/pdia.2015.54749.
Vancouver
Sokołowska-Wojdyło M, Olek-Hrab K, Ruckemann-Dziurdzińska K. Primary cutaneous lymphomas: diagnosis and treatment. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2015;32(5):368-383. doi:10.5114/pdia.2015.54749.
Primary cutaneous lymphomas (CLs) are a heterogeneous group of lymphoproliferative neoplasms, with lymphatic proliferation limited to the skin with no involvement of lymph nodes, bone marrow or viscera at the diagnosis. Cutaneous lymphomas originate from mature T-lymphocytes (65% of all cases), mature B-lymphocytes (25%) or NK cells. Histopathological evaluation including immunophenotyping of the skin biopsy specimen is the basis of the diagnosis, which must be complemented with a precise staging of the disease and identification of prognostic factors, to allow for the choice of the best treatment method as well as for the evaluation of the treatment results.